NanoVibronix Announces Reimbursement Approvals for PainShield(R) in the U.S.
Reimbursement aligned with AHIP and CMS initiatives to help combat the opioid epidemic ELMSFORD, NY / ACCESSWIRE / March 25,...
News
Oryzon to Present at Upcoming International Conferences
13th Annual International Partnering Conference BIO-Europe Spring VIENNA 14th International Conference on Alzheimer's and Parkinson's Diseases (ADPD2019) LISBON MADRID, SPAIN...
WNDM Medical Inc. Announces Planned Reverse Stock Split and Company Name Change to Sanara MedTech Inc.
FORT WORTH, TX / ACCESSWIRE / March 25, 2019 / WNDM Medical Inc. (OTCQB: WNDM) Based in Fort Worth, Texas,...
Heads Up Checkup, Inc. to Present at the 146th NIBA Investment Conference
ANAHEIM HILLS, CA / ACCESSWIRE / March 25, 2019 / Heads Up Checkup, Inc., an emerging SAAS provider of mental...
Atlantic Weedboard to Present at the 146th NIBA Investment Conference
New York, NY / ACCESSWIRE / March 25, 2019 / Atlantic WeedBoard (www.atlanticWeedBoard.com), a newly formed information center for the...
Global Health & Pharma (”GHP”) Recognises InnerScope Hearing Technologies (OTCQB: INND) In the 2019 Biotechnology Awards Winners
UNITED KINGDOM / ACCESSWIRE / March 25, 2019 / GHP Magazine has awarded InnerScope Hearing Technologies, ("InnerScope") Best Hearing Aid...
Adial Pharmaceuticals Announces Filing to Update the Prior Registration Statement Registering the Shares Underlying the ADILW Warrants
CHARLOTTESVILLE, VA / ACCESSWIRE / March 25, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused...
AsclepiX Therapeutics, Inc. Strengthens Board of Directors, Welcomes Steven Altschuler, MD
AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing novel peptide therapies, including AXT107 for retinal disease and novel peptides...
Glycotope Expands Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies to Include Marketed Anti-Tumor Antibodies
- GATTO Study Extension to Evaluate Gatipotuzumab and Tomuzotuximab or marketed anti-EGFR Monoclonal Antibody Drugs in refractory metastatic solid tumors...
Kadmon Announces Susan Wiviott to Step Down from Board of Directors
NEW YORK, NY / ACCESSWIRE / March 22, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Susan Wiviott...
DNA Dynamics, Inc. Announces ”SunKissed Hemp” as Brand Name for its Hemp Products
NEW YORK, NY / ACCESSWIRE / March 22, 2019 / DNA Dynamics, Inc. (OTC PINK: DNAD) announces today that they...
CanadaBis Capital Inc. and 1926360 Alberta Ltd. (dba Stigma Pharmaceuticals) in the Final Stages of Proposed Amalgamation
CALGARY, AB / ACCESSWIRE / March 21, 2019 / CanadaBis Capital Inc. "TSXV: CANB.P" ("CanadaBis" or the "Company"), an Alberta...
Evotec AG to Report Fiscal Year 2018 Results on 28 March 2019
HAMBURG, GERMANY / ACCESSWIRE / March 21, 2019 / Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report...
CorMedix Inc. Announces Appointment of Phoebe Mounts as Executive Vice President and General Counsel
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 21, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
Hancock Jaffe Enrolls Four Additional Patients for First-in-Human VenoValve Study
Implantations to Take Place by End of April with Initial Data Expected in June 2019 IRVINE, CA / ACCESSWIRE /...
Heat Biologics to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy
DURHAM, NC / ACCESSWIRE / March 21, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed...
Alimera Sciences Announces Approval for ILUVIEN (R) in Kuwait
Kuwait Added to the Growing Number of Countries with Approval for ILUVIEN in the Middle East ATLANTA, GA / ACCESSWIRE...
Southbridge Fitness Center Announces its Grand Opening in Fort Greene, Brooklyn NY – Brooklyn Borough President Eric Adams to Speak at Grand Opening Celebration
Brooklyn Borough President Eric Adams to speak as Southbridge Fitness Center announces its grand opening on Myrtle Avenue in Fort...
Oryzon to Present Latest Advances of Vafidemstat at Oppenheimer’s 29th Annual Healthcare Conference
Highlighting encouraging preliminary first human data in REIMAGINE Phase IIa trial Complete data on Borderline Personality Disorder (BPD) cohort will...
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy
ELMSFORD, NY / ACCESSWIRE / March 20, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's...